SCARLET THERAPEUTICS LIMITED
Research and experimental development on biotechnology
SCARLET THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Science Creates Old Market Midland Road Bristol Somerset BS2 0JZ England
Full company profile for SCARLET THERAPEUTICS LIMITED (13536278), an active life sciences and medical technology company based in Bristol, England. Incorporated 28 Jul 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2022–2025)
Cash in Bank
N/A
Net Assets
£491.29k
Total Liabilities
£55.26k
Turnover
N/A
Employees
8
Debt Ratio
10%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Jul Year End | 2024 31 Jul Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (3)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | May 2023 | Seed |
| Investor 2 | May 2023 | Seed |
| Investor 3 | May 2023 | Seed |
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Ashley Mark Toye | Director | British | England | 28 Jul 2021 | Active |
| Sparey, Timothy Jason, Dr | Director | British | United Kingdom | 30 Mar 2026 | Active |
See all 8 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Science Creates Ventures
Ceased 12 Aug 2022
Professor Ashley Mark Toye
Ceased 12 Aug 2022
Scv Kcp Nominees Ltd
Ceased 21 Jun 2024
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 19 May 2026 | Officers | Termination of Janet Frayne as director on 30 Mar 2026 | |
| 19 May 2026 | Officers | Termination of Andrew David Wilson as director on 30 Mar 2026 | |
| 19 May 2026 | Officers | Appointment of Mr Didier Shaun Philip Cowling as director on 2 Apr 2026 | |
| 30 Apr 2026 | Capital | Allotment of shares (GBP 365.9933) on 30 Apr 2026 | |
| 24 Apr 2026 | Capital | Allotment of shares (GBP 328.9396) on 7 Apr 2026 |
Termination of Janet Frayne as director on 30 Mar 2026
Termination of Andrew David Wilson as director on 30 Mar 2026
Appointment of Mr Didier Shaun Philip Cowling as director on 2 Apr 2026
Allotment of shares (GBP 365.9933) on 30 Apr 2026
Allotment of shares (GBP 328.9396) on 7 Apr 2026
Recent Activity
Latest Activity
Termination of Janet Frayne as director on 30 Mar 2026
1 weeks ago on 19 May 2026
Termination of Andrew David Wilson as director on 30 Mar 2026
1 weeks ago on 19 May 2026
Appointment of Mr Didier Shaun Philip Cowling as director on 2 Apr 2026
1 weeks ago on 19 May 2026
Allotment of shares (GBP 365.9933) on 30 Apr 2026
1 months ago on 30 Apr 2026
Allotment of shares (GBP 328.9396) on 7 Apr 2026
1 months ago on 24 Apr 2026